• News
• Research areas
• Contract research
• Staff
• Publications
• Postgraduate study
• Collaborations
• Job vacancies
• Contact us

Clore Laboratory: News
Diabetes, Obesity and Metabolic Research

8 March 2007 – Mike Cawthorne reviews obesity drug research for Foresight programme

Mike Cawthorne, Director of Metabolic Research, Clore Laboratory, University of Buckingham, UK, has provided a vision of the impact of drug research on the treatment of obesity 25 years hence for the UK government Office of Science and Innovation Foresight programme on ‘Tackling Obesities: Future Choices’.

The short review looks at drug treatments for obesity since the 1970s, how current drugs were discovered and their effectiveness, and the current status of anti-obesity drug research, including cutting edge research and the likely impact of this research in the next 25 years.

The review is an open access publication in Obesity Reviews. The full reference is:

M A Cawthorne. Opportunities and challenges for the development of pharmacological therapies for obesity treatment. Obesity Reviews. 2007 Mar;8 Suppl 1:131–136
doi:10.1111/j.1467-789X.2007.00332.x.

Clore Laboratory